CK Life Sciences Intl (Holdings) Inc

Holdings History for Transcode Therapeutics, Inc. - Common Stock (RNAZ)

Symbol: RNAZ on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 83,285 shares
Security Ownership %: 9.1%

CK Life Sciences Int'l., (Holdings) Inc. ownership in Transcode Therapeutics, Inc. Common Stock (RNAZ)

28 Oct 2025 - CK Life Sciences Int'l., (Holdings) Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 83,285 shares of Transcode Therapeutics, Inc. Common Stock (RNAZ). This represents 9.1% ownership of the company. In their previous filing dated 16 Oct 2025, CK Life Sciences Intl (Holdings) Inc had reported owning 83,285 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
CK Life Sciences Int'l., (Holdings) Inc.	9.1%	0%	$871,161	83,285	0		$10.46	13D/A	27 Oct 2025	28 Oct 2025, 17:39
CK Life Sciences Int'l., (Holdings) Inc.	9.1%		$871,161	83,285			$10.46	13D	08 Oct 2025	16 Oct 2025, 16:05